Hepatitis A virus (HAV) is a human pathogen that continues to pose a worldwide health problem, especially in developing countries. The virus is an atypical member of the picornavirus family, and appears to represent a unique genus. Although it shares the same general structure and genome organization with other picornavirsuses, it has only limited nucleotide or amino acid sequence homology to members of any of the other picornavirus groups. In addition, numerous aspects of HAV growth and replication in cultured cells differ markedly from those of other picornaviruses. Whereas other picornaviruses undergo rapid, lytic growth cycles, HAV replicates slowly and asynchronously and establishes persistent infections. We have previously initiated studies to identify and characterize the molecular biology of HAV in order to understand its growth phenotype. In addition, we have produced HAV proteins in recombinant systems to evaluate the feasibility of a subunit type vaccine for this infection. In this application, we propose to determine the structures of the HAV caps id proteins and their precursors, and to analyze the roles of specific HAV gene products and sequences as viral growth determinants. Capsid protein processing and modification will be defined by both biochemical and genetic methods. The 5' noncoding region will be analyzed for its role in translational efficiency and host range restriction, and the viral proteins, RNA sequences and biochemical activities that regulate viral RNA synthesis will be evaluated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026350-07
Application #
2063329
Study Section
Experimental Virology Study Section (EVR)
Project Start
1988-04-01
Project End
1998-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Graff, J; Richards, O C; Swiderek, K M et al. (1999) Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol 73:6015-23
Graff, J; Ehrenfeld, E (1998) Coding sequences enhance internal initiation of translation by hepatitis A virus RNA in vitro. J Virol 72:3571-7
Graff, J; Cha, J; Blyn, L B et al. (1998) Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation. J Virol 72:9668-75
Jia, X Y; Van Eden, M; Busch, M G et al. (1998) trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol 72:7972-7
Davis, H L; McCluskie, M J; Gerin, J L et al. (1996) DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci U S A 93:7213-8
Jia, X Y; Tesar, M; Summers, D F et al. (1996) Replication of hepatitis A viruses with chimeric 5' nontranslated regions. J Virol 70:2861-8
Ehrenfeld, E; Brown, D; Jia, X Y et al. (1995) Antibodies against viral nonstructural proteins in response to infection with poliovirus. J Infect Dis 171:845-50
Harmon, S A; Emerson, S U; Huang, Y K et al. (1995) Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J Virol 69:5576-81
Tesar, M; Pak, I; Jia, X Y et al. (1994) Expression of hepatitis A virus precursor protein P3 in vivo and in vitro: polyprotein processing of the 3CD cleavage site. Virology 198:524-33
Jia, X Y; Summers, D F; Ehrenfeld, E (1993) Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology 193:515-9

Showing the most recent 10 out of 20 publications